Dry-Concentrate is a high-quality dry hemodialysis concentrate developed to meet the growing need for efficient, cost-effective, and space-saving dialysis solutions. Designed with precision, it ensures optimal performance while simplifying storage and handling in clinical environments.

Compositions Available:

• Dry-Concentrate with and without Dextrose
• Dry-Concentrate Potassium-free formula
• Dry-Concentrate Calcium-free formula

Packaging:

Supplied in sealed, moisture-resistant aluminium foil pouches, paired with bicarbonate concentrate for 10 dialysis sessions.

Shelf Life:

36 months from the date of manufacture.

The introduction of Dry-Concentrate in the dialysis segment was driven by critical logistical, clinical, and economic challenges faced by hospitals and dialysis centers across the country.

Traditionally, Part A (acid concentrate) used in hemodialysis has been available in liquid form, while Part B (bicarbonate) was required to be in powder form due to its instability once converted to liquid. The short shelf life of reconstituted bicarbonate solutions (6–8 hours) created operational difficulties at treatment sites.

After engaging with healthcare professionals, procurement teams, and dialysis technicians, it became evident that storage was a major pain point. Facilities lacked sufficient storage space for bulky liquid canisters, leading to frequent stockouts, disrupted dialysis schedules, and increased pressure on procurement logistics.

Dry-Concentrate addresses this gap by offering a high-quality powdered acid concentrate that is compact, easier to store, and significantly reduces transportation costs. By eliminating the need for heavy liquid canisters, it allows facilities to optimize storage and manage inventory more efficiently.

Additionally, Dry-Concentrate has demonstrated clinical advantages — including a reduction in heparin usage by up to 45%, minimized patient inflammation, and safe usage in patients with liver disorders.

The cost savings from reduced transportation and packaging are passed directly to healthcare providers, making Dry-Concentrate a smarter and more economical solution for modern dialysis care.

• Reduces Heparin usage by up to 45%, cutting anticoagulant costs significantly
• Highly effective for heparin-free dialysis due to natural anti-coagulant properties
• Enables 30% increase in dialyzer reuse, improving operational efficiency
• Enhances dialysis adequacy by improving Kt/V and URR parameters
• Minimizes complications associated with Heparin use such as Osteoporosis, Pruritus, and lipid disturbances
• Eliminates acetate-related metabolic issues
• Reduces systemic inflammation in patients undergoing chronic dialysis
• Safe for patients with liver disorders or impaired hepatic function
• Helps in reducing metabolic acidosis during treatment

Logistical & Operational Benefits :

• Nephroplus Group of Dialysis Centers
• Fortis Group of Hospitals
• Sandor Nephro Services Pvt. Ltd. (Fresenius)
• Narayana Hrudayalaya Group of Hospitals
• KIMS Group of Hospitals
• B Braun Group of Dialysis Centers
• P.D. Hinduja National Hospital & Medical Research Centre